Skip to main content

Month: May 2022

With 7.61% CAGR, Orthopedic Joint Replacement Market Size worth USD 26.89 Billion in 2027

According to Fortune Business Insights, the global Orthopedic Joint Replacement Market size is projected to reach USD 26.89 Billion by 2027, at CAGR of 7.61% during forecast period; Increasing Product Awareness among Patients in North America to Aid Growth Pune, India, May 10, 2022 (GLOBE NEWSWIRE) — The orthopedic joint replacement market size is expected to experience considerable growth by reaching USD 26.89 billion by 2027. Fortune Business Insights in its report, titled “Orthopedic Joint Replacement Market, 2020-2027”, mentions that the market stood at USD 20.00 billion in 2019 and is projected to exhibit a CAGR of 7.61% during the forecast period. The demand for joint replacement is surging among the geriatric population due to rising incidents of osteoarthritis. The introduction of patient specific implants and...

Continue reading

With 4.7% CAGR, Dry Eye Syndrome Market Size worth USD 6.54 Billion in 2027

According to Fortune Business Insights, the global Dry Eye Syndrome Market size is projected to reach USD 6.54 Billion in 2027, at CAGR of 4.7% during forecast period; Growing Awareness about Eye Disorders to Incite Business Development Pune, India, May 10, 2022 (GLOBE NEWSWIRE) — The dry eye syndrome market size is expected to reach USD 6.54 billion by 2027, exhibiting a CAGR of 4.7% during the forecast period. The increasing prevalence of chronic eye disorders and diseases will spur demand for eye treatment, which, in turn, will aid the expansion of the market. “Dry Eye Syndrome Market Share, Size & COVID-19 Impact Analysis, By Product (Anti-inflammatory and Artificial Tears & Lubricants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2020-2027.”...

Continue reading

With 7.2% CAGR, Influenza Vaccine Market Size worth USD 10.73 Billion in 2028

According To Fortune Business Insights, the Global Influenza Vaccine Market Size Is Projected To Reach USD 10.73 Billion by 2028, Exhibiting A CAGR Of 7.2% During Forecast Period; Rising Prevalence Of Influenza Vaccine With Favorable Reimbursement Policies To Drive Growth Pune, India, May 10, 2022 (GLOBE NEWSWIRE) — The Influenza Vaccine Market size is expected to showcase considerable growth by reaching USD 10.73 billion by 2028 while exhibiting a CAGR of 7.2% between 2021 and 2028. The report further mentions that the market stood at USD 5.86 billion in 2020. According to the Centers for Disease Control and Prevention (CDC), around 13 million flu cases were reported globally during 2019-20. Besides, the flu outbreaks lead to several thousand deaths and take a toll on the healthcare settings. Therefore, the increasing focus on...

Continue reading

AFC Gamma, Inc. Announces Financial Results for First Quarter 2022

WEST PALM BEACH, Fla., May 10, 2022 (GLOBE NEWSWIRE) — AFC Gamma, Inc. (NASDAQ:AFCG) (“AFCG” or “AFC Gamma”) today announced its results for the first quarter of 2022. First Quarter 2022 HighlightsNet income of $10.2 million in Q1 2022, or $0.53 per basic weighted average share of common stock Distributable earnings1 of $11.9 million in Q1 2022, or $0.62 per basic weighted average share of common stock Paid a dividend of $0.55 per common share on April 15, 2022 for Q1 2022, representing a 10% increase from the prior quarter Distributable earnings significantly exceeded the declared dividend for the fourth consecutive quarter Book value of $17.04 per share as of March 31, 2022, an increase of $0.43, or 2.6%, compared to December 31, 2021“We are pleased with our strong performance in the first quarter and continued growth so...

Continue reading

BBQ Holdings, Inc. Reports Results for First Quarter 2022

MINNEAPOLIS, May 10, 2022 (GLOBE NEWSWIRE) — BBQ Holdings, Inc. (NASDAQ: BBQ) (the “Company”), an innovating global franchisor, owner and operator of restaurants, today reported financial results for the first fiscal quarter ended April 3, 2022. First Quarter Highlights:                           First Quarter(dollars in thousands, except per share data)     2022     2021     2020     2019  Total revenue   $ 64,184   $ 37,319   $ 23,855   $ 14,193  Net income (loss)   $ 767   $ 799   $ 13,707   $ 82  Earnings (loss) per diluted share   $ 0.07   $ 0.08   $ 1.49   $ 0.01  Adjusted net income (loss)   $ 1,138   $ 811   $ (484 ) $ 489  Adjusted earnings (loss) per diluted share   $ 0.11   $ 0.09   $ (0.05 ) $ 0.05  Cash EBITDA   $ 3,748   $ 3,220   $ (457 ) $ 1,030  Restaurant-level margins     6.4 %   9.1 %   (1.9 )%   (1.7 )%Prime...

Continue reading

Form 8.3 – [RWS Holdings plc – 09 05 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree RWS HOLDINGS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Middlefield Banc Corp. Announces 2022 Second Quarter Cash Dividend Payment

MIDDLEFIELD, Ohio, May 10, 2022 (GLOBE NEWSWIRE) — Middlefield Banc Corp. (NASDAQ: MBCN) today announced that the Company’s Board of Directors declared a quarterly cash dividend of $0.17 per common share payable on June 15, 2022, to shareholders of record on June 3, 2022. Middlefield Banc Corp., headquartered in Middlefield, Ohio, is the bank holding company of The Middlefield Banking Company with total assets of $1.32 billion at March 31, 2022. The bank operates 16 full-service banking centers and an LPL Financial® brokerage office serving Beachwood, Chardon, Cortland, Dublin, Garrettsville, Mantua, Middlefield, Newbury, Orwell, Plain City, Powell, Solon, Sunbury, Twinsburg, and Westerville. The Bank also operates a Loan Production Office in Mentor, Ohio. Additional information is available at www.middlefieldbank.bank This press...

Continue reading

Platinex Announces Acquisition of Titanium-Vanadium Claims Adjacent to W2 Cu-Ni-PGE Project and Receipt of Government Grant for Shining Tree Gold Project

W2 Property Claim AcquisitionTORONTO, May 10, 2022 (GLOBE NEWSWIRE) — Platinex Inc. (CSE: PTX) (Frankfurt 9PX) (“Platinex” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Endurance Elements Inc. (“Endurance Elements”), has acquired additional mining claims adjacent to the W2 Copper-Nickel-PGE Project (the “W2 Project” or “W2”) in the Ring of Fire in Ontario, Canada. The new claims combined with the existing claims cover an 8-10 km long, northeast-trending magnetic high (the “Bartman Lake North Magnetic High” or “BNMH”) and include the area of a Titanium-Vanadium (Ti-V) discovery made by Aurora Platinum Corporation in 2001. See image. The discovery drill hole LH01-10 bored in the BNMH intersected multiple intercepts of disseminated to massive titano-magnetite mineralization hosted within diorite-leucogabbro-anorthosite-gabbro-magnetite...

Continue reading

Form 8.3 – [Ideagen plc – 09 05 2022] – (HHL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: HARGREAVE HALE LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDEAGEN PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDEAGEN PLC AS AN ASSOCIATE OF THE CANACCORD...

Continue reading

Acerus Reports First Quarter 2022 Financial Results

TORONTO, May 10, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three-month period ended March 31, 2022. Unless otherwise noted, all amounts are in US dollars and are prepared in accordance with International Financial Reporting Standards (“IFRS”). Recent HighlightsTotal Natesto® prescriptions in the US rose 43% year-over-year in the first quarter of 2022 and were up approximately 26% sequentially over the fiscal 2021 fourth quarter The rollout of Natesto® across the US remains on track, underscored by focused operational execution of the Company’s growth strategy As previously announced, Acerus completed the acquisition of Serenity Pharmaceuticals LLC (“Serenity”) on March 7, 2022, including the global rights to its...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.